@article{61ebb341d36c4c00ae68dcb0424aac74,
title = "Development of childhood asthma prediction models using machine learning approaches",
abstract = "BACKGROUND: Respiratory symptoms are common in early life and often transient. It is difficult to identify in which children these will persist and result in asthma. Machine learning (ML) approaches have the potential for better predictive performance and generalisability over existing childhood asthma prediction models. This study applied ML approaches to predict school-age asthma (age 10) in early life (Childhood Asthma Prediction in Early life, CAPE model) and at preschool age (Childhood Asthma Prediction at Preschool age, CAPP model).METHODS: Clinical and environmental exposure data was collected from children enrolled in the Isle of Wight Birth Cohort (N = 1368, ∼15% asthma prevalence). Recursive Feature Elimination (RFE) identified an optimal subset of features predictive of school-age asthma for each model. Seven state-of-the-art ML classification algorithms were used to develop prognostic models. Training was performed by applying fivefold cross-validation, imputation, and resampling. Predictive performance was evaluated on the test set. Models were further externally validated in the Manchester Asthma and Allergy Study (MAAS) cohort.RESULTS: RFE identified eight and twelve predictors for the CAPE and CAPP models, respectively. Support Vector Machine (SVM) algorithms provided the best performance for both the CAPE (area under the receiver operating characteristic curve, AUC = 0.71) and CAPP (AUC = 0.82) models. Both models demonstrated good generalisability in MAAS (CAPE 8-year = 0.71, 11-year = 0.71, CAPP 8-year = 0.83, 11-year = 0.79) and excellent sensitivity to predict a subgroup of persistent wheezers.CONCLUSION: Using ML approaches improved upon the predictive performance of existing regression-based models, with good generalisability and ability to rule in asthma and predict persistent wheeze.",
keywords = "asthma, childhood, machine learning, prediction",
author = "Kothalawala, {Dilini M} and Murray, {Clare S} and Angela Simpson and Adnan Custovic and Tapper, {William J} and Arshad, {S Hasan} and Holloway, {John W} and Rezwan, {Faisal I} and {STELAR/UNICORN Investigators}",
note = "Funding Information: The authors would like to acknowledge the help of all the staff at the David Hide Asthma and Allergy Research Centre in undertaking the assessments of the Isle of Wight Birth Cohort. The authors would also like to thank the IOWBC and MAAS study participants and their parents for their continued support and enthusiasm. Recruitment and initial assessment for the first 4?yearsof age for the IOWBC was supported by the Isle of Wight Health Authority. The 10-year follow-up of the IOWBC was funded by the National Asthma Campaign, UK (Grant No 364). MAAS was supported by the Asthma UK Grants No 301 (1995?1998), No 362 (1998?2001), No 01/012 (2001?2004), No 04/014 (2004?2007), BMA James Trust (2005) and The JP Moulton Charitable Foundation (2004-current), The North west Lung Centre Charity (1997-current) and the Medical Research Council (MRC) G0601361 (2007?2012), MR/K002449/1 (2013?2014) and MR/L012693/1 (2014?2018). UNICORN (Unified Cohorts Research Network): Disaggregating asthma MR/S025340/1. The authors would also like to acknowledge the use of the IRIDIS High Performance Computing Facility, and associated support services at the University of Southampton, in the completion of this work. This work was supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre and a University of Southampton Presidential Research Studentship. Replication analysis in MAAS was supported by the Medical Research Council as part of UNICORN (Unified Cohorts Research Network): Disaggregating asthma MR/S025340/1. Angela Simpson and Clare Murray are supported by the NIHR Manchester Biomedical Research Centre. Funding Information: This work was supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre and a University of Southampton Presidential Research Studentship. Replication analysis in MAAS was supported by the Medical Research Council as part of UNICORN (Unified Cohorts Research Network): Disaggregating asthma MR/S025340/1. Angela Simpson and Clare Murray are supported by the NIHR Manchester Biomedical Research Centre. Funding Information: The authors would like to acknowledge the help of all the staff at the David Hide Asthma and Allergy Research Centre in undertaking the assessments of the Isle of Wight Birth Cohort. The authors would also like to thank the IOWBC and MAAS study participants and their parents for their continued support and enthusiasm. Recruitment and initial assessment for the first 4 yearsof age for the IOWBC was supported by the Isle of Wight Health Authority. The 10‐year follow‐up of the IOWBC was funded by the National Asthma Campaign, UK (Grant No 364). MAAS was supported by the Asthma UK Grants No 301 (1995–1998), No 362 (1998–2001), No 01/012 (2001–2004), No 04/014 (2004–2007), BMA James Trust (2005) and The JP Moulton Charitable Foundation (2004‐current), The North west Lung Centre Charity (1997‐current) and the Medical Research Council (MRC) G0601361 (2007–2012), MR/K002449/1 (2013–2014) and MR/L012693/1 (2014–2018). UNICORN (Unified Cohorts Research Network): Disaggregating asthma MR/S025340/1. The authors would also like to acknowledge the use of the IRIDIS High Performance Computing Facility, and associated support services at the University of Southampton, in the completion of this work. Publisher Copyright: {\textcopyright} 2021 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.",
year = "2021",
month = nov,
day = "7",
doi = "10.1002/clt2.12076",
language = "English",
volume = "11",
journal = "Clinical and Translational Allergy",
issn = "2045-7022",
publisher = "Wiley",
number = "9",
}